The ins and outs of reverse cholesterol transport

Annals of Medicine

Volumn 36, Issue 2, 2004, Pages 135-145

  Groen, Albert K ^a   Oude Elferink, Ronald P J ^a   Verkade, Henkjan J ^a   Kuipers, Folkert ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

ATP binding casette transporters; Bile; Cholesterol; High density lipoprotein; Lipoprotein; LXR; Reverse cholesterol transport

Indexed keywords

ABC TRANSPORTER; CHOLESTEROL; CHYLOMICRON; CYCLIC AMP; PROTEIN KINASE C; STEROL;

ATHEROGENESIS; ATHEROMA; BILE SECRETION; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL LIVER LEVEL; CHOLESTEROL METABOLISM; CHOLESTEROL SYNTHESIS; CHOLESTEROL TRANSPORT; FAMILIAL HYPERCHOLESTEROLEMIA; FATTY ACID TRANSPORT; HUMAN; LIPID STORAGE; MICELLE; PRIORITY JOURNAL; REVIEW; TANGIER DISEASE; TRANSCRIPTION REGULATION; UPREGULATION;

ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; BILE; BIOLOGICAL TRANSPORT; CHOLESTEROL; HUMANS; INTESTINAL ABSORPTION; LIVER;

EID: 1942473060     PISSN: 07853890     EISSN: None     Source Type: Journal    
DOI: 10.1080/07853890310020635     Document Type: Review

References (109)

1. Dietschy JM, Turley SD, Spady DK. Role of liver in the maintenance of cholesterol and low density lipoprotein homeostasis in different animal species, including humans. J Lipid Res 1993;34:1637-59.
2. Glomset JA, Norum KR. The metabolic role of lecithin: cholesterol acyltransferase: perspectives form pathology. Adv Lipid Res 1973;11:1-65.
3. Kannel WB, Wilson PW. Efficacy of lipid profiles in prediction of coronary disease. Am Heart J 1992;124:768-74.
4. Durrington P. HDL in risk prediction and its direct and indirect involvement in atherogenesis. Atheroscler Suppl 2002;3:3-12.
5. Jolley CD, Woollett LA, Turley SD, Dietschy JM. Centripetal cholesterol flux to the liver is dictated by events in the peripheral organs and not by the plasma high density lipoprotein or apolipoprotein a-i concentration. Journal of Lipid Research 1998;39:2143-9.
6. Osono Y, Woollett LA, Marotti KR, Melchior GW, Dietschy JM. Centripetal cholesterol flux from extrahepatic organs to the liver is independent of the concentration of high density lipoprotein-cholesterol in plasma. Proc Natl Acad Sci USA 1996;93:4114-9.
7. Alam K, Meidell RS, Spady DK. Effect of up-regulating individual steps in the reverse cholesterol transport pathway on reverse cholesterol transport in normolipidemic mice. J Biol Chem 2001;276:15641-9.
8. Eriksson M, Carlson LA, Miettinen TA, Angelin B. Stimulation of fecal steroid excretion after infusion of recombinant proapolipoprotein A-I. Potential reverse cholesterol transport in humans. Circulation 1999;100:594-8.
9. Angelin B, Parini P, Eriksson M. Reverse cholesterol transport in man: promotion of fecal steroid excretion by infusion of reconstituted HDL. Atheroscler Suppl 2002;3:23-30.
10. Nanjee MN, Cooke CJ, Garvin R, Semeria F, Lewis G, Olszewski WL, et al. Intravenous apoA-I/lecithin discs increase pre-beta-HDL concentration in tissue fluid and stimulate reverse cholesterol transport in humans. J Lipid Res 2001;42:1586-93.
11. Fell DA. Metabolic control analysis: a survey of its theoretical and experimental development. Biochem J 1992;286:313-30.
12. Brooks-Wilson A, Marcil M, Clee SM, Zhang LH, Roomp K, van Dam M, et al. Mutations in abc1 in tangier disease and familial high-density lipoprotein deficiency. Nat Genet 1999;22:336-45.
13. Marcil M, Brooks-Wilson A, Clee SM, Roomp K, Zhang LH, Yu L, et al. Mutations in the abc1 gene in familial hdl deficiency with defective cholesterol efflux. Lancet 1999;354:1341-6.
14. Bodzioch M, Orso E, Klucken T, Langmann T, Bottcher L, Diederich W, et al. The gene encoding atp-binding cassette transporter 1 is mutated in tangier disease. Nat Genet 1999;22:347-51.
15. Oram JF. Tangier disease and ABCA1. Biochim Biophys Acta 2000;1529:321-30.
16. Clee SM, Kastelein JJ, van Dam M, Marcil M, Roomp K, Zwarts KY, et al. Age and residual cholesterol efflux affect HDL cholesterol levels and coronary artery disease in ABCA1 heterozygotes. J Clin Invest 2000;106:1263-70.
17. Mott S, Yu L, Marcil M, Boucher B, Rondeau C, Genest J. Decreased cellular cholesterol efflux is a common cause of familial hypoalphalipoproteinemia: role of the ABCA1 gene mutations [In Process Citation]. Atherosclerosis 2000;152:457-68.
18. Wang J, Burnett JR, Near S, Young K, Zinman B, Hanley AJ, et al. Common and rare ABCA1 variants affecting plasma HDL cholesterol. Arterioscler Thromb Vasc Biol 2000;20:1983-9.
19. Santamarina-Fojo S, Peterson K, Knapper C, Qiu Y, Freeman L, Cheng JF, et al. Complete genomic sequence of the human ABCA1 gene: analysis of the human and mouse ATP-binding cassette A promoter. Proc Natl Acad Sci USA 2000;97:7987-92.
20. Walter M, Reinecke H, Gerdes U, Nofer JR, Hobbel G, Seedorf U, et al. Defective regulation of phosphatidylcholine-specific phospholipases c and d in a kindred with tangier disease - evidence for the involvement of phosphatidylcholine breakdown in hdl-mediated cholesterol efflux mechanisms. J Clin Invest 1996;98:2315-23.
21. von Eckardstein A, Chirazi A, Schuler-Luttmann S, Walter M, Kastelein JJ, Geisel J, et al. Plasma and fibroblasts of Tangier disease patients are disturbed in transferring phospholipids onto apolipoprotein A-I. J Lipid Res 1998;39:987-98.
22. Remaley AT, Schumacher UK, Stonik JA, Farsi BD, Nazih H, Brewer HB, Jr. Decreased reverse cholesterol transport from Tangier disease fibroblasts. Acceptor specificity and effect of brefeldin on lipid efflux. Arterioscler Thromb Vasc Biol 1997;17:1813-21.
23. Orso E, Broccardo C, Kaminski WE, Bottcher A, Liebisch G, Dtobnik W, et al. Transport of lipids from golgi to plasma membrane is defective in tangier disease patients and Abe1-deficient mice. Nat Genet 2000;24:192-6.
24. Mott S, Yu L, Marcil M, Boucher B, Rondeau C, Genest J, Jr. Decreased cellular cholesterol efflux is a common cause of familial hypoalphalipoproteinemia: role of the ABCA1 gene mutations. Atherosclerosis 2000;152:457-68.
25. Mendez AJ. Cholesterol efflux mediated by apolipoproteins is an active cellular process distinct from efflux mediated by passive diffusion. J Lipid Res 1997;38:1807-21.
26. Lawn RM, Wade DP, Garvin MR, Wang X, Schwartz K, Porter JG, et al. The Tangier disease gene product ABC1 controls the cellular apolipoprotein-mediated lipid removal pathway [see comments]. J Clin Invest 1999;104:R25-31.
27. Eberhart GP, Mendez AJ, Freeman MW. Decreased cholesterol efflux from fibroblasts of a patient without Tangier disease, but with markedly reduced high density lipoprotein cholesterol levels. J Clin Endocrinol Metab 1998;83:836-46.
28. Czarnecka H, Yokoyama S. Regulation of cellular cholesterol efflux by lecithin: cholesterol acyltransferase reaction through nonspecific lipid exchange. J Biol Chem 1996;271:2023-8.
29. Langmann T, Klucken J, Reil M, Liebisch G, Luciani MF, Chimini G, et al. Molecular cloning of the human ATP-binding cassette transporter 1 (hABC1): evidence for steroldependent regulation in macrophages. Biochem Biophys Res Commun 1999;257:29-33.
30. Oram JF, Lawn RM, Garvin MR, Wade DP. ABCA1 is the cAMP-inducible apolipoprotein receptor that mediates cholesterol secretion from macrophages. J Biol Chem 2000;275:34508-11.
31. Haidar B, Mott S, Boucher B, Lee CY, Marcil M, Genest J, Jr. Cellular cholesterol efflux is modulated by phospholipid-derived signaling molecules in familial HDL deficiency/Tangier disease fibroblasts. J Lipid Res 2001;42:249-57.
32. Repa JJ, Turley SD, Lobaccaro JA, Medina J, Li L, Lustig K, et al. Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers [see comments]. Science 2000;289:1524-9.
33. Repa JJ, Mangelsdorf DJ. The Role of Orphan Nuclear Receptors in the Regulation of Cholesterol Homeostasis. Annu Rev Cell Dev Biol 2000;16:459-81.
34. Wang Y, Oram JF. Unsaturated fatty acids inhibit cholesterol efflux from macrophages by increasing degradation of ATP-binding cassette transporter A1. J Biol Chem 2002;277:5692-7.
35. Singaraja RR, Bocher V, James ER, Clee SM, Zhang LH, Leavitt BR, et al. Human ABCA1 BAC transgenic mice show increased high density lipoprotein cholesterol and ApoAI-dependent efflux stimulated by an internal promoter containing liver X receptor response elements in intron 1. J Biol Chem 2001;276:33969-79.
36. Vaisman BL, Lambert G, Amar M, Joyce C, Ito T, Shamburek RD, et al. ABCA1 overexpression leads to hyperalphalipoproteinemia and increased biliary cholesterol excretion in transgenic mice. J Clin Invest 2001;108:303-9.
37. Wellington CL, Brunham LR, Zhou S, Singaraja RR, Visscher H, Gelfer A, et al. Alterations of plasma lipids in mice via adenovirual mediated hepatic overexpression of human ABCA1. J Lipid Res 2003;1:1.
38. Plosch T, Kok T, Bloks VW, Smit MJ, Havinga R, Chimini G, et al. Increased hepatobiliary and fecal cholesterol excretion upon activation of the liver X receptor is independent of ABCA1. J Biol Chem 2002;277:33870-7.
39. Groen AK, Bloks VW, Bandsma RH, Ottenhoff R, Chimini G, Kuipers F. Hepatobiliary cholesterol transport is not impaired in Abca1-null mice lacking HDL. J Clin Invest 2001;108:843-50.
40. Drobnik W, Lindenthal B, Lieser B, Ritter M, Weber TC, Liebisch G, et al. ATP-binding cassette transporter A1 (ABCA1) affects total body sterol metabolism. Gastroenterology 2001;120:1203-11.
41. Haghpassand M, Bourassa PA, Francone OL, Aiello RJ. Monocyte/macrophage expression of ABCA1 has minimal contribution to plasma HDL levels. J Clin Invest 2001;108:1315-20.
42. van Eck M, Bos IS, Kaminski WE, Orso E, Rothe G, Twisk J, et al. Leukocyte ABCA1 controls susceptibility to atherosclerosis and macrophage recruitment into tissues. Proc Natl Acad Sci USA 2002;99:6298-303.
43. Rogler G, Trumbach B, Klima B, Lackner KJ, Schmitz G. Hdl-mediated efflux of intracellular cholesterol is impaired in fibroblasts from tangier disease patients. Arteriosclerosis Thromb Vasc Biol 1995;15:683-90.
44. Mendez AJ, Uint L. Apolipoprotein-mediated cellular cholesterol and phospholipid efflux depend on a functional golgi apparatus. J Lipid Res 1996;37:2510-24.
45. Hovingh GK, Van Wijland MJ, Brownlie A, Bisoendial RB, Hayden MR, Kastelein JJ, et al. The role of the ABCA1 transporter and cholesterol efflux in familial hypoalphalipoproteinemia. J Lipid Res 2003;16:16.
46. Basso F, Freeman L, Knapper CL, Remaley A, Stonik J, Neufeld EB, et al. Role of the hepatic ABCA1 transporter in modulating intrahepatic cholesterol and plasma HDL cholesterol concentrations. J Lipid Res 2003;44:296-302.
47. Wang N, Tall AR. Regulation and Mechanisms of ATP-Binding Cassette Transporter A1-Mediated Cellular Cholesterol Efflux. Arterioscler Thromb Vasc Biol 2003;8:8.
48. Kiss RS, McManus DC, Franklin V, Tan WL, McKenzie A, Chimini G, et al. The lipidation by hepatocytes of human apolipoprotein A-I occurs by both ABCA1-dependent and -independent pathways. J Biol Chem 2003;278:10119-27.
49. Vaughan AM, Oram JF. ABCA1 redistributes membrane cholesterol independent of apolipoprotein interactions. J Lipid Res 2003;16:16.
50. Hamon Y, Broccardo C, Chambenoit O, Luciani MF, Toti F, Chaslin S, et al. ABC1 promotes engulfment of apoptotic cells and transbilayer redistribution of phosphatidylserine. Nat Cell Biol 2000;2:399-406.
51. Wellington CL, Walker EK, Suarez A, Kwok A, Bissada N, Singaraja R, et al. ABCA1 mRNA and Protein Distribution Pattetns Predict Multiple Different Roles and Levels of Regulation. Lab Invest 2002;82:273-83.
52. Schmitz G, Buechler C. ABCA1: regulation, trafficking and association with heteromeric proteins. Ann Med 2002;34:334-47.
53. McNeish J, Aiello RJ, Guyot D, Turi T, Gabel C, Aldinger C, et al. High density lipoprotein deficiency and foam cell accumulation in mice with targeted disruption of ATP-binding cassette transporter-1. Proc Natl Acad Sci USA 2000;97:4245-50.
54. Christiansen-Weber TA, Voland JR, Wu Y, Ngo K, Roland BL, Nguyen S, et al. Functional loss of ABCA1 in mice causes severe placental malformation, aberrant lipid distribution, and kidney glomerulonephritis as well as high-density lipoprotein cholesterol deficiency. Am J Pathol 2000;157:1017-29.
55. Aiello RJ, Brees D, Bourassa PA, Royer L, Lindsey S, Coskran T, et al. Increased atherosclerosis in hyperlipidemic mice with inactivation of ABCA1 in macrophages. Arterioscler Thromb Vasc Biol 2002;22:630-7.
56. Wang DQ, Carey MC. Measurement of intestinal cholesterol absorption by plasma and fecal dual-isotope ratio, mass balance, and lymph fistula methods in the mouse: an analysis of direct versus indirect methodologies. J Lipid Res 2003;44:1042-59.
57. Tall AR, Small DM. Body cholesterol removal: role of plasma high-density lipoproteins. Adv Lipid Res 1980;17:1-51.
58. Mulligan JD, Flowers MT, Tebon A, Bitgood JJ, Wellington C, Hayden MR, et al. ABCA1 is essential for efficient basolateral cholesterol efflux during the absorption of dietary cholesterol in chickens. J Biol Chem 2003;278:13356-66.
59. Higgins ME, Davies JP, Chen FW, Ioannou YA. Niemann-Pick C1 is a late endosome-resident protein that transiently associates with lysosomes and the trans-Golgi network. Mol Genet Metab 1999;68:1-13.
60. Lange Y, Ye J, Rigney M, Steck T. Cholesterol movement in Niemann-Pick type C cells and in cells treated with amphiphiles. J. Biol. Chem 2000;275:17468-75.
61. Amigo L, Mendoza H, Castro J, Quinones V, Miquel JF, Zanlungo S. Relevance of Niemann-Pick type C1 protein expression in controlling plasma cholesterol and biliary lipid secretion in mice. Hepatology 2002;36:819-28.
62. Walter M, Davies JP, Ioannou YA. Telomerase immortalization upregulates Rab9 expression and restores LDL cholesterol egress from Niemann-Pick C1 late endosomes. J Lipid Res 2003;44:243-53.
63. Robins SJ, Fasulo JM. High density lipoproteins, but not other lipoproteins, provide a vehicle for sterol transport to bile. J Clin Invest 1997;99:380-4.
64. Robins SJ, Fasulo JM. Delineation of a novel hepatic route for the selective transfer of unesterified sterols from high-density lipoproteins to bile: studies using the perfused rat liver. Hepatology 1999;29:1541-8.
65. Rigotti A, Trigatti BL, Penman M, Rayburn H, Herz J, Krieger M. A targeted mutation in the murine gene encoding the high density lipoprotein (HDL) receptor scavenger receptor class B type I reveals its key role in HDL metabolism. Proc Natl Acad Sci USA 1997;94:12610-5.
66. Mardones P, Quinones VV, Amigo L, Moreno M, Miquel JF, Schwarz M, et al. Hepatic cholesterol and bile acid metabolism and intestinal cholesterol absorption in scavenger receptor class B type I-deficient mice. J Lipid Res 2001;42:170-80.
67. Zanlungo S, Amigo A, Mendoza H, Morena F, Miquel J-F, Rigotti A, et al. Biliary lipid secretion in Niemann-Pick C1 protein deficient mice. Gastronterology 2000;118:2354.
68. Friedland N, Liou HL, Lobel P, Stock AM. Structure of a cholesterol-binding protein deficient in Niemann-Pick type C2 disease. Proc Natl Acad Sci USA 2003;100:2512-7.
69. Frolov A, Zielinski SE, Crowley JR, Dudley-Rucker N, Schaffer JE, Ory DS. NPC1 and NPC2 regulate cellular cholesterol homeostasis through generation of LDL-derived oxysterols. J Biol Chem 2003;28:28.
70. Small DM. Role of ABC transporters in secretion of cholesterol from liver into bile. Proc Natl Acad Sci USA 2003;100:4-6.
71. Fuchs M, Hafer A, Munch C, Kannenberg F, Teichmann S, Scheibner J, et al. Disruption of the sterol carrier protein 2 gene in mice impairs biliary lipid and hepatic cholesterol metabolism. J Biol Chem 2001;276:48058-65.
72. Amigo L, Zanlungo S, Miquel JF, Click JM, Hyogo H, Cohen DE, et al. Hepatic overexpression of sterol carrier protein-2 inhibits VLDL production and reciprocally enhances biliary lipid secretion. J Lipid Res 2003;44:399-407.
73. Billington D, Coleman R. Effects of bile salts of human erythrocytes. Plasma membrane vesiculation, phospholipid solubilization and their possible relationships to bile secretion. Biochim.Biophys.Acta 1978;509:33-47.
74. Billington D, Coleman R. The removal of membrane components from human erythrocytes by glycocholate. Biochem Soc Tran 1978;6:286-8.
75. Crawford JM, Crawford AR, Hatch VC, Stearns RC, Barnes S, Godleski JJ. Hepatocellular secretion of biliary lipid: bile salt-induced vesiculation of the canalicular membrane outer leaflet. In: Hofmann AF, Paumgartner G, Stiehl A, eds. Bile acids in gastroenterology. Basic and clinical advances. 1 ed. Dordrecht: Kluwer Acad. Publ.; 1995:254-7.
76. Crawford JM, Hatch VC, Groen AK, Oude Elferink RPJ. Bile canalicular vesicles are markedly decreased in mdr2 knockout mice:electron microscopy of cryofixed liver. Hepatology 1995;22:316A.
77. Crawford JM, Möckel G-M, Crawford AR, Hagen SJ, Hatch VC, Barnes S, et al. Imaging biliary lipid secretion in the rat: ultrastructural evidence for vesiculation of the hepatocyte canalicular membrane. J Lipid Res 1995;36:2147-63.
78. Oude Elferink RPJ, Bakker CTM, Roelofsen H, Middelkoop E, Ottenhoff R, Heijn M, et al. Accumulation of organic anion in intracellular vesicles of cultured rat hepatocytes is mediated by the canalicular multispecific organic anion transporter. Hepatology 1993;17:434-44.
79. Oude Elferink RPJ, Ottenhoff R, Van Wijland MJA, Smit JJM, Schinkel AH, Groen AK. Regulation of biliary lipid secretion by mdr2-P-glycoprotein in the mouse. J Clin Invest 1995;95:31-8.
80. Smit JJM, Schinkel AH, Oude Elferink RPJ, Groen AK, Wagenaar E, Van Deemter L, et al. Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease. Cell 1993;75:451-62.
81. Oude Elferink RPJ, Ottenhoff R, van Wijland M, Frijters CMG, van Nieuwkerk C, Groen AK. Uncoupling of biliary phospholipid and cholesterol secretion in mice with reduced expression of mdr2 P-glycoprotein. J Lipid Res 1996;37:1065-75.
82. Verkade HJ, Havinga R, Gerding A, Vonk RJ, Kuipers F. Mechanism of Bile Acid-Induced Biliary Lipid Secretion in the Rat: Effect of Conjugated Bilirubin. Am J Physiol 1993;264:G462-9.
83. Verkade HJ, Vonk RJ, Kuipers F. Mechanism of bile acid-induced biliary lipid secretion. Hepatology 1994;17:1074-80.
84. Verkade HJ, Vonk RJ, Kuipers F. New insights into the mechanism of bile acid-induced biliary lipid secretion. Hepatology 1995;21:1174-89.
85. Kuipers F, Oude Elferink RP, Verkade HJ, Groen AK. Mechanisms and (patho)physiological significance of biliary cholesterol secretion. [review] [106 refs]. Sub-Cellular Biochemistry 1997;28:295-318.
86. Berge KE, Tian H, Graf GA, Yu L, Grishin NV, Schultz J, et al. Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters. Science 2000;290:1771-5.
87. Lee MH, Lu K, Hazard S, Yu H, Shulenin S, Hidaka H, et al. Identification of a gene, ABCG5, important in the regulation of dietary cholesterol absorption. Nat Genet 2001;27:79-83.
88. Patel SB, Honda A, Salen G. Sitosterolemia: exclusion of genes involved in reduced cholesterol biosynthesis. J Lipid Res 1998;39:1055-61.
89. Berger GM, Pegoraro RJ, Patel SB, Naidu P, Rom L, Hidaka H, et al. HMG-CoA reductase is not the site of the primary defect in phytosterolemia. J Lipid Res 1998;39:1046-54.
90. Salen G, Patel S, Batta AK. Sitosterolemia. Cardiovasc Drug Rev 2002;20:255-70.
91. Graf GA, Li WP, Gerard RD, Gelissen I, White A, Cohen JC, et al. Coexpression of ATP-binding cassette proteins ABCG5 and ABCG8 permits their transport to the apical surface. J Clin Invest 2002;110:659-69.
92. Yu L, Hammer RE, Li-Hawkins J, Von Bergmann K, Lutjohann D, Cohen JC, et al. Disruption of Abcg5 and Abcg8 in mice reveals their crucial role in biliary cholesterol secretion. Proc Natl Acad Sci USA 2002;99:16237-42.
93. Yu L, Li-Hawkins J, Hammer RE, Berge KE, Horton JD, Cohen JC, et al. Overexpression of ABCG5 and ABCG8 promotes biliary cholesterol secretion and reduces fractional absorption of dietary cholesterol. J Clin Invest 2002;110:671-80.
94. Shiau YF, Kelemen RJ, Reed MA. Acidic mucin layer facilitates micelle dissociation and fatty acid diffusion. Am J Physiol 1990;259:G671-5.
95. Compassi S, Werder M, Weber FE, Boffelli D, Hauser H, Schulthess G. Comparison of cholesterol and sitosterol uptake in different brush border membrane models. Biochemistry 1997;36:6643-52.
96. Boffelli D, Compassi S, Werder M, Weber FE, Phillips MC, Schulthess G, et al. The uptake of cholesterol at the small-intestinal brush border membrane is inhibited by apolipo-proteins. FEBS Lett 1997;411:7-11.
97. Boffelli D, Weber FE, Compassi S, Werder M, Schulthess G, Hauser H. Reconstitution and further characterization of the cholesterol transport activity of the small-intestinal brush border membrane. Biochemistry 1997;36:10784-92.
98. Urban S, Zieseniss S, Werder M, Hauser H, Budzinski R, Engelmann B. Scavenger receptor BI transfers major lipoprotein-associated phospholipids into the cells. J Biol Chem 2000;275:33409-15.
99. Werder M, Han CH, Wehrli E, Bimmler D, Schulthess G, Hauser H. Role of scavenger receptors SR-BI and CD36 in selective sterol uptake in the small intestine. Biochemistry 2001;40:11643-50.
100. Voshol PJ, Schwarz M, Rigotti A, Krieger M, Groen AK, Kuipers F. Down-regulation of intestinal scavenger receptor class B, type I (SR- BI) expression in rodents under conditions of deficient bile delivery to the intestine. Biochem J 2001;356:317-25.
101. Schulthess G, Compassi S, Werder M, Han CH, Phillips MC, Hauser H. Intestinal sterol absorption mediated by scavenger receptors is competitively inhibited by amphipathic peptides and proteins. Biochemistry 2000;39:12623-31.
102. Altmann SW, Davis HR, Jr, Yao X, Laverty M, Compton DS, Zhu LJ, et al. The identification of intestinal scavenger receptor class B, type I (SR-BI) by expression cloning and its role in cholesterol absorption. Biochim Biophys Acta 2002;1580:77-93.
103. Nozaki S, Tanaka T, Yamashita S, Sohmiya K, Yoshizumi T, Okamoto F, et al. CD36 mediates long-chain fatty acid transport in human myocardium: complete myocardial accumulation defect of radiolabeled long-chain fatty acid analog in subjects with CD36 deficiency. Mol Cell Biochem 1999;192:129-35.
104. Luiken JJ, Miskovic D, Arumugam Y, Glatz JF, Bonen A. Skeletal muscle fatty acid transport and transporters. Int J Sport Nutr Exerc Metab 2001;11:S92-6.
105. Chen M, Yang Y, Braunstein E, Georgeson KE, Harmon CM. Gut expression and regulation of FAT/CD36: possible role in fatty acid transport in rat enterocytes. Am J Physiol Endocrinol Metab 2001;281:E916-23.
106. Goudriaan JR, Dahlmans VE, Febbraio M, Teusink B, Romijn JA, Havekes LM, et al. Intestinal lipid absorption is not affected in CD36 deficient mice. Mol Cell Biochem 2002;239:199-202.
107. Yu L, York J, von Bergmann K, Lutjohann D, Cohen JC, Hobbs HH. Stimulation of cholesterol excretion by the liver X receptor agonist requires ATP-binding cassette transporters G5 and G8. J Biol Chem 2003;278:15565-70.
108. Schwarz M, Davis DL, Vick BR, Russell DW. Genetic analysis of intestinal cholesterol absorption in inbred mice. J Lipid Res 2001;42:1801-11.
109. Sehayek E, Duncan EM, Lutjohann D, Von Bergmann K, Ono JG, Batta AK, et al. Loci on chromosomes 14 and 2, distinct from ABCG5/ABCG8, regulate plasma plant sterol levels in a C57BL/6J x CASA/Rk intercross. Proc Natl Acad Sci USA 2002;99:16215-9.